ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
인간 간 모델 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 13.7%를 나타내 43억 9,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 ai와 머신러닝의 통합, 환자 유래 간 모델, 생체 공학의 획기적인 개선, 의약품의 안전성 및 독성 시험 요구 사항, 가상 임상시험으로 인한 것으로 예측됩니다. 예측 기간의 주요 동향에는 다장기 모델 통합, 3D 바이오프린팅 혁신, 고처리량 스크리닝 기능, 혈관 신생 및 혈류 강화, 윤리 및 규정 준수 등이 포함됩니다.
향후 5년간의 성장률 13.7%라고 하는 예측은 전회 예측으로부터 0.1%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 영국과 일본에서 개발된 3D 바이오프린트 간 모델 및 독성 시험 플랫폼의 가격을 상승시키고 의약품 개발 지연 및 의약품 연구개발(R&D) 비용 상승을 초래하여 미국 정밀의료 도입을 방해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
인간 간 모델 시장 성장은 간 질환의 이환율 증가에 의해 견인될 것으로 예측됩니다. 간 질환에는 간의 적절한 기능에 영향을 미치는 다양한 장애가 포함됩니다. 인간 간 모델을 포함한 새로운 연구 개발은 간 질환의 이해를 깊게 하고 의약품 개발을 개선할 잠재력을 가지고 있습니다. 그 결과, 간 질환의 증례 증가가 인간 간 모델 시장 확대를 촉진하고 있습니다. 예를 들어, 2022년 9월, Caner Australia는 2022년 호주에서 새롭게 진단되는 간암의 경우가 약 2,905명이라고 보고했고 간 관련 건강 문제에 대처하는 것의 중요성을 강조했습니다. 간 질환의 유병률 증가는 의학 연구 및 치료 전략의 진보에서 인간 간 모델의 중요한 역할을 강조합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 인간 간 모델 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 인간 간 모델 시장 : 성장률 분석
세계의 인간 간 모델 시장 실적 : 규모와 성장(2019-2024년)
세계의 인간 간 모델 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 인간 간 모델 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 인간 간 모델 시장 : 제품별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
간 오가노이드
간-온-어-칩
2차원 모델
동물 모델
3D 바이오프린팅
세계의 인간 간 모델 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
교육용
신약 개발
기타 용도
세계의 인간 간 모델 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
연구기관
제약회사
기타 최종 사용자
세계의 인간 간 모델 시장 : 간 오가노이드 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
1차 간 오가노이드
유도만능줄기세포(iPSC) 유래 오가노이드
세계의 인간 간 모델 시장 : 간-온-어-칩 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
미이크로플루이딕 간 칩
다중 장기 칩 시스템
세계의 인간 간 모델 시장 : 2차원 모델 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
간 세포 배양
간 세포주
세계의 인간 간 모델 시장 : 동물 모델 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
설치류 모델
대형 동물 모델
세계의 인간 간 모델 시장 : 3D 바이오프린팅 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
바이오프린팅 간 조직
하이브리드 바이오프린팅 모델
제7장 지역별/국가별 분석
세계의 인간 간 모델 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 인간 간 모델 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
인간 간 모델 시장 : 경쟁 구도
인간 간 모델 시장 : 기업 프로파일
Corning Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
EISCO Scientific LLC : 개요, 제품 및 서비스, 전략 및 재무 분석
BioIVT LLC : 개요, 제품 및 서비스, 전략 및 재무 분석
Cyprotex plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Emulate Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Cellink AB
Nortis Inc.
InSphero AG
CN Bio Innovations Ltd.
TissUse GmbH
Ascendance Biotechnology Inc.
HemoShear Therapeutics Inc.
Cyfuse Biomedical
MIMETAS BV
Biopredic International Sarl
ZenBio
Hurel Corporation
Regenovo
Pandorum
Organovo Holdings Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
인간 간 모델 시장(2029년) : 새로운 기회를 제공하는 국가
인간 간 모델 시장(2029년) : 새로운 기회를 제공하는 부문
인간 간 모델 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
The human liver model represents a dual-lobed model of the human liver, primarily responsible for filtering blood from the digestive tract. It is utilized to illustrate and assess the toxic effects of drug candidates on the liver.
The primary product types of human liver models include liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting. Liver organoids are 3D structures generated from stem cells that self-organize through mechanisms similar to those in vivo. These models find applications in education, drug discovery, and other fields, and are employed by research institutes, pharmaceutical companies, and other entities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The human liver model market research report is one of a series of new reports from The Business Research Company that provides human liver model market statistics, including human liver model industry global market size, regional shares, competitors with a human liver model market share, detailed human liver model market segments, market trends and opportunities, and any further data you may need to thrive in the human liver model industry. This human liver model market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The human liver model market size has grown rapidly in recent years. It will grow from $2.34 billion in 2024 to $2.62 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to drug development needs, advancements in biotechnology, animal testing alternatives, rising liver diseases, regulatory demands.
The human liver model market size is expected to see rapid growth in the next few years. It will grow to $4.39 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to ai and machine learning integration, patient-derived liver models, bioengineering breakthroughs, drug safety and toxicity testing requirements, virtual clinical trials. Major trends in the forecast period include multi-organ models integration, 3d bioprinting innovations, high-throughput screening capability, enhanced vascularization and blood flow, ethical and regulatory compliance.
The forecast of 13.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of precision medicine by inflating prices of 3D bio-printed liver models and toxicity testing platforms developed in the UK and Japan, resulting in delayed drug development and higher pharmaceutical research and development (R&D) costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growth of the human liver model market is anticipated to be driven by the increasing incidence of liver disease. Liver disease encompasses various disorders that affect the proper functioning of the liver. The emerging area of research involving human liver models holds the potential to enhance understanding of liver diseases and improve drug development. Consequently, the escalating cases of liver diseases are fostering the expansion of the human liver model market. For instance, in September 2022, Caner Australia reported approximately 2,905 new cases of liver cancer diagnosed in Australia in 2022, highlighting the significance of addressing liver-related health concerns. The rising prevalence of liver disease underscores the crucial role of human liver models in advancing medical research and therapeutic strategies.
The growth of the human liver model market is further expected to be propelled by the increasing number of clinical trials. Clinical trials, essential for evaluating the safety and efficacy of medical interventions, treatments, or drugs in humans, frequently employ human liver models to simulate drug metabolism and assess hepatotoxicity in the context of pharmaceutical development. As of May 2023, there are 452,604 registered clinical trials globally, signifying a substantial increase from previous counts. The surge in clinical trials emphasizes the growing demand for human liver models in facilitating robust research practices and advancing drug discovery initiatives.
A prominent trend in the human liver model market is the focus on product innovation by major companies. Companies operating in this market are actively engaged in developing innovative products to enhance their market positioning. In April 2023, LifeNet Health Life Sciences introduced TruVivo, a groundbreaking liver system composed entirely of human cells. TruVivo represents a 2D+ solution that combines the robust data associated with 3D models with the flexibility and simplicity of a 2D model, offering a significant advancement in liver research and drug development.
Major players in the human liver model market are directing their efforts toward the development of advanced systems, particularly single-organ higher throughput (HT) systems. These innovative systems aim to improve the adoption of predictive human liver models and provide a competitive advantage. For instance, in February 2023, UK-based organ-on-a-chip company CN Bio launched PhysioMimix with Liver-48 plate, a single-organ higher throughput (HT) system designed to overcome challenges in the adoption of predictive human liver models for drug discovery. The Liver-48 plate, a multi-chip consumable, facilitates larger-scale comparative studies on drug disposition, efficacy, and safety.
In April 2023, AnaBios Corporation, a biotechnology research firm, acquired Cell Systems for an undisclosed amount. This acquisition is designed to enhance AnaBios' capabilities in drug discovery and development by integrating Cell Systems' advanced cell-based technologies. As a result, this move strengthens AnaBios' portfolio in human-relevant models, allowing for more accurate predictions of drug efficacy and safety. Cell Systems is a biotechnology research company based in the US.
Major companies operating in the human liver model market include Corning Incorporated, EISCO Scientific LLC, BioIVT LLC, Cyprotex plc, Emulate Inc., Cellink AB, Nortis Inc., InSphero AG, CN Bio Innovations Ltd., TissUse GmbH, Ascendance Biotechnology Inc., HemoShear Therapeutics Inc., Cyfuse Biomedical, MIMETAS BV, Biopredic International Sarl, ZenBio, Hurel Corporation, Regenovo, Pandorum, Organovo Holdings Inc., BICO Group, Hepregen Corporation, Kirkstall Ltd., HepaLife Technologies Inc., Cellaion SA.
North America was the largest region in the human liver model market in 2024. The regions covered in the human liver model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the human liver model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The human liver model market consists of sales of 3B scientific liver and prime baker fiber liver model. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Human Liver Model Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on human liver model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for human liver model ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The human liver model market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Liver Organoids; Liver-On-A-Chip; 2D Models; Animal Models; 3D Bioprinting
2) By Application: Educational; Drug Discovery; Other Applications
3) By End Users: Research Institutes; Pharmaceutical Companies; Other End Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Human Liver Model Market Characteristics
3. Human Liver Model Market Trends And Strategies
4. Human Liver Model Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Human Liver Model Growth Analysis And Strategic Analysis Framework
5.1. Global Human Liver Model PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Human Liver Model Market Growth Rate Analysis
5.4. Global Human Liver Model Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Human Liver Model Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Human Liver Model Total Addressable Market (TAM)
6. Human Liver Model Market Segmentation
6.1. Global Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Liver Organoids
Liver-On-A-Chip
2D Models
Animal Models
3D Bioprinting
6.2. Global Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Educational
Drug Discovery
Other Applications
6.3. Global Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research Institutes
Pharmaceutical Companies
Other End Users
6.4. Global Human Liver Model Market, Sub-Segmentation Of Liver Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
